HK1010369A1 - Rapamycin metabolites - Google Patents

Rapamycin metabolites

Info

Publication number
HK1010369A1
HK1010369A1 HK98110983A HK98110983A HK1010369A1 HK 1010369 A1 HK1010369 A1 HK 1010369A1 HK 98110983 A HK98110983 A HK 98110983A HK 98110983 A HK98110983 A HK 98110983A HK 1010369 A1 HK1010369 A1 HK 1010369A1
Authority
HK
Hong Kong
Prior art keywords
mass
charge ratio
rapamycin
virtue
useful
Prior art date
Application number
HK98110983A
Other languages
English (en)
Inventor
Uwe Christians
Karl Friedrich Sewing
Martin Sattler
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of HK1010369A1 publication Critical patent/HK1010369A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98110983A 1991-05-14 1998-09-25 Rapamycin metabolites HK1010369A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/699,505 US5776943A (en) 1991-05-14 1991-05-14 Rapamycin metabolites

Publications (1)

Publication Number Publication Date
HK1010369A1 true HK1010369A1 (en) 1999-06-17

Family

ID=24809620

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98110983A HK1010369A1 (en) 1991-05-14 1998-09-25 Rapamycin metabolites

Country Status (13)

Country Link
US (1) US5776943A (xx)
EP (1) EP0514144B1 (xx)
JP (1) JP3183554B2 (xx)
KR (1) KR920021552A (xx)
AT (1) ATE174918T1 (xx)
AU (1) AU659452B2 (xx)
CA (1) CA2068349C (xx)
DE (1) DE69227942T2 (xx)
DK (1) DK0514144T3 (xx)
ES (1) ES2126586T3 (xx)
GR (1) GR3029767T3 (xx)
HK (1) HK1010369A1 (xx)
IE (1) IE921525A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9302569D0 (en) * 1993-02-10 1993-03-24 Smithkline Beecham Plc Novel compound
GB9315914D0 (en) * 1993-07-31 1993-09-15 Smithkline Beecham Plc Novel compound
US5849730A (en) * 1994-08-31 1998-12-15 Pfizer Inc. Process for preparing demethylrapamycins
US5922730A (en) * 1996-09-09 1999-07-13 American Home Products Corporation Alkylated rapamycin derivatives
IT1289815B1 (it) * 1996-12-30 1998-10-16 Sorin Biomedica Cardio Spa Stent per angioplastica e relativo procedimento di produzione
US6015809A (en) * 1998-08-17 2000-01-18 American Home Products Corporation Photocyclized rapamycin
MXPA05013879A (es) * 2003-06-18 2006-06-27 Genelux Corp Virus de la vaccinia recombinantes modificados y otros microorganismos, y usos de los mismos.
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
US8430055B2 (en) 2008-08-29 2013-04-30 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8425459B2 (en) 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US8998846B2 (en) 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
US20080175887A1 (en) 2006-11-20 2008-07-24 Lixiao Wang Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) * 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US3993749A (en) * 1974-04-12 1976-11-23 Ayerst Mckenna And Harrison Ltd. Rapamycin and process of preparation
US4885171A (en) * 1978-11-03 1989-12-05 American Home Products Corporation Use of rapamycin in treatment of certain tumors
US4316885A (en) * 1980-08-25 1982-02-23 Ayerst, Mckenna And Harrison, Inc. Acyl derivatives of rapamycin
US4401653A (en) * 1981-03-09 1983-08-30 Ayerst, Mckenna & Harrison Inc. Combination of rapamycin and picibanil for the treatment of tumors
US4650803A (en) * 1985-12-06 1987-03-17 University Of Kansas Prodrugs of rapamycin
US4981792A (en) * 1988-06-29 1991-01-01 Merck & Co., Inc. Immunosuppressant compound
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
EP0413532A3 (en) * 1989-08-18 1991-05-15 Fisons Plc Macrocyclic compounds
US5023264A (en) * 1990-07-16 1991-06-11 American Home Products Corporation Rapamycin oximes
US5023263A (en) * 1990-08-09 1991-06-11 American Home Products Corporation 42-oxorapamycin
US5023262A (en) * 1990-08-14 1991-06-11 American Home Products Corporation Hydrogenated rapamycin derivatives
JPH05112573A (ja) * 1991-04-17 1993-05-07 American Home Prod Corp ラパマイシンのカルバミン酸エステル類
US5091389A (en) * 1991-04-23 1992-02-25 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant
JP3108192B2 (ja) * 1991-05-07 2000-11-13 アメリカン・ホーム・プロダクツ・コーポレイション 免疫抑制剤、抗炎症剤または抗真菌剤用ラパマイシンの還元生成物
US5102876A (en) * 1991-05-07 1992-04-07 American Home Products Corporation Reduction products of rapamycin

Also Published As

Publication number Publication date
DE69227942T2 (de) 1999-08-26
US5776943A (en) 1998-07-07
KR920021552A (ko) 1992-12-18
CA2068349A1 (en) 1992-11-15
JP3183554B2 (ja) 2001-07-09
AU1615492A (en) 1992-11-19
DE69227942D1 (de) 1999-02-04
ATE174918T1 (de) 1999-01-15
AU659452B2 (en) 1995-05-18
CA2068349C (en) 2002-04-09
ES2126586T3 (es) 1999-04-01
JPH05130884A (ja) 1993-05-28
EP0514144A2 (en) 1992-11-19
EP0514144B1 (en) 1998-12-23
IE921525A1 (en) 1992-11-18
EP0514144A3 (en) 1993-03-03
GR3029767T3 (en) 1999-06-30
DK0514144T3 (da) 1999-08-23

Similar Documents

Publication Publication Date Title
EP0514144A3 (en) Rapamycin metabolites
AU4149797A (en) Multipole ion guide ion trap mass spectrometry
AU7515996A (en) Miniature quadrupole mass spectrometer array
WO1998056023A3 (en) Miniature micromachined quadrupole mass spectrometer array and method of making the same
EP0459602A3 (en) Mass spectrometric high-frequency quadrupole cage with superposed multipole fields
WO1997015054A3 (en) A flash eeprom memory with separate reference array
GB2280305B (en) Quadrupole ion trap
AU1932095A (en) Multipole ion guide for mass spectrometry
GB9715258D0 (en) Introduction of ions from ion sources into mass spectrometers
CA2067541A1 (en) Reduction products of rapamycin
CA2114262A1 (en) Ion trap mass spectrometer method and apparatus for improved sensitivity
EP0237259A3 (en) Mass spectrometer
CA2382823A1 (en) Rapid response mass spectrometer system
AU3638093A (en) Sample nebulizer and evaporation chamber for ICP and MIP emission or mass spectrometry and spectrometers comprising the same
GB9409980D0 (en) Ejection of ions from ion traps by combined electrical dipole and quadrupole fields
AU3668599A (en) Ion trap mass spectrometer with electrospray ionization
DE69118121T2 (de) Quadrupolmassenspektrometers
EP0581600A3 (en) Method of implementing a high sensitivity quadrupole ion trap.
ZA976105B (en) Method for injection of externally produced ions into a quadrupole ion trap.
CA2101156A1 (en) Chemical Ionization Mass Spectrometry Method Using Notch Filter
DE69402513D1 (de) Quadrupolmassenspektrometer
NO913790L (no) Separator for smaa partikler.
Brandenberger et al. New developments in the field of mass spectrometry and GC-MS and their applications to toxicological analysis
Ishibashi et al. Diethylhydrogensilyl-cyclic diethylsilylene derivatives in the gas chromatography—mass spectrometry of hydroxylated steroids: IV. Hydrocortisone
GB1515791A (en) General purpose atomic spectrometer

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20040511